Science 37
Culver City
About Science 37
Science 37 is making the promise of virtual trials the new reality. By engaging with patients from the comfort of their own home, the company provides access to patients who can never be reached by traditional site-based research models. Its virtual model has proven to enroll faster, retain patients at a higher rate, and reach a more representative patient population. Science 37 has conducted more virtual (or decentralized), interventional trials than any other company, using an expansive, in-house network of telemedicine investigators and home-health nurses. The company's research is powered by the industry’s most comprehensive, fully integrated clinical trial platform purpose-built to conduct virtual trials.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 501 – 1,000
- Estimated revenue: $10K – $50K
- Total funding: $347.5M
- Funding stage: M&A
- Last round: Post-IPO Equity (Oct 2021)
- Ticker: nasdaq:SNCE
- Website: science37.com
- Phone: (984) 377-3737
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Home Health Care
Social Profiles
Canonical: https://fsome.com/organization/science-37-56418 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.